EcoR1 Capital as of Sept. 30, 2022
Portfolio Holdings for EcoR1 Capital
EcoR1 Capital holds 75 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Prothena Corp SHS (PRTA) | 20.7 | $702M | 12M | 60.63 | |
| Apellis Pharmaceuticals | 10.4 | $354M | 5.2M | 68.30 | |
| Sarepta Therapeutics (SRPT) | 9.8 | $332M | 3.0M | 110.54 | |
| Anaptysbio Inc Common (ANAB) | 5.7 | $192M | 7.5M | 25.51 | |
| Arvinas Ord (ARVN) | 4.1 | $139M | 3.1M | 44.49 | |
| Xencor (XNCR) | 4.1 | $137M | 5.3M | 25.98 | |
| Galapagos Nv Spon Adr | 4.0 | $136M | 3.2M | 42.64 | |
| Morphic Hldg (MORF) | 3.3 | $112M | 4.0M | 28.30 | |
| Springworks Therapeutics (SWTX) | 2.9 | $99M | 3.5M | 28.53 | |
| ACADIA Pharmaceuticals (ACAD) | 2.9 | $98M | 6.0M | 16.36 | |
| Relay Therapeutics (RLAY) | 2.7 | $93M | 4.2M | 22.37 | |
| Kura Oncology (KURA) | 2.7 | $91M | 6.6M | 13.66 | |
| Mirati Therapeutics | 2.1 | $71M | 1.0M | 69.84 | |
| Zai Lab Adr (ZLAB) | 2.0 | $69M | 2.0M | 34.20 | |
| Gossamer Bio (GOSS) | 1.5 | $50M | 4.2M | 11.98 | |
| Allogene Therapeutics (ALLO) | 1.4 | $49M | 4.5M | 10.80 | |
| Avidity Biosciences Ord | 1.4 | $47M | 2.9M | 16.33 | |
| Design Therapeutics (DSGN) | 1.3 | $43M | 2.6M | 16.72 | |
| Seagen | 1.2 | $39M | 286k | 136.83 | |
| Alector (ALEC) | 1.1 | $38M | 4.1M | 9.46 | |
| Revolution Medicines (RVMD) | 1.0 | $36M | 1.8M | 19.72 | |
| Atea Pharmaceuticals (AVIR) | 1.0 | $35M | 6.2M | 5.69 | |
| Edgewise Therapeutics (EWTX) | 1.0 | $34M | 3.5M | 9.84 | |
| 2seventy Bio Common Stock | 1.0 | $34M | 2.3M | 14.55 | |
| Nuvation Bio Com Cl A (NUVB) | 0.9 | $31M | 14M | 2.24 | |
| Voyager Therapeutics (VYGR) | 0.8 | $28M | 4.8M | 5.92 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.8 | $26M | 1.3M | 19.64 | |
| Janux Therapeutics (JANX) | 0.6 | $19M | 1.4M | 13.54 | |
| Kymera Therapeutics (KYMR) | 0.5 | $17M | 796k | 21.77 | |
| Tango Therapeutics (TNGX) | 0.4 | $15M | 4.2M | 3.62 | |
| Cullinan Oncology (CGEM) | 0.4 | $15M | 1.1M | 12.82 | |
| Ventyx Biosciences (VTYX) | 0.4 | $14M | 400k | 34.91 | |
| Chinook Therapeutics | 0.4 | $14M | 690k | 19.66 | |
| Akouos | 0.4 | $13M | 2.0M | 6.76 | |
| Centessa Pharmaceuticals Sponsored Ads | 0.4 | $13M | 3.2M | 4.02 | |
| Ovid Therapeutics (OVID) | 0.3 | $11M | 6.1M | 1.84 | |
| Oric Pharmaceuticals (ORIC) | 0.3 | $11M | 3.4M | 3.20 | |
| Poseida Therapeutics I (PSTX) | 0.3 | $9.4M | 2.7M | 3.53 | |
| Arcutis Biotherapeutics (ARQT) | 0.2 | $7.9M | 415k | 19.11 | |
| Ngm Biopharmaceuticals | 0.2 | $7.1M | 541k | 13.08 | |
| Hookipa Pharma Inc equity | 0.2 | $6.7M | 5.0M | 1.34 | |
| Precision Biosciences Ord | 0.2 | $6.5M | 5.0M | 1.30 | |
| Argenx Se Sponsored Adr (ARGX) | 0.2 | $6.2M | 18k | 353.06 | |
| Gracell Biotechnologies Sponsored Ads | 0.2 | $6.2M | 1.9M | 3.22 | |
| Selecta Biosciences | 0.2 | $5.7M | 3.5M | 1.64 | |
| Geron Corporation (GERN) | 0.2 | $5.4M | 2.3M | 2.34 | |
| Aveo Pharmaceuticals Com New | 0.2 | $5.4M | 651k | 8.23 | |
| Erasca (ERAS) | 0.2 | $5.3M | 678k | 7.80 | |
| Graphite Bio | 0.1 | $5.0M | 1.6M | 3.17 | |
| Jiya Acquisition Corp Com Cl A | 0.1 | $5.0M | 500k | 9.97 | |
| Frazier Lifesciences Acqu Cl A Shs | 0.1 | $4.9M | 488k | 9.97 | |
| Aligos Therapeutics | 0.1 | $4.3M | 3.9M | 1.10 | |
| Surface Oncology | 0.1 | $4.1M | 3.9M | 1.04 | |
| Health Sciences Acq Corp 2 Ord Shs | 0.1 | $4.0M | 400k | 9.90 | |
| Praxis Precision Medicines I | 0.1 | $3.4M | 1.5M | 2.27 | |
| Macrogenics (MGNX) | 0.1 | $3.2M | 931k | 3.46 | |
| Ascendis Pharma A/s Sponsored Adr | 0.1 | $2.8M | 27k | 103.24 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.1 | $2.2M | 963k | 2.24 | |
| Kinnate Biopharma | 0.1 | $2.1M | 175k | 11.95 | |
| Bcls Acquisition Corp Com Cl A | 0.1 | $2.0M | 200k | 10.02 | |
| Eucrates Biomedical Acqu Cor SHS | 0.1 | $2.0M | 200k | 10.02 | |
| 5 01 Acquisition Corp Com Cl A | 0.1 | $2.0M | 200k | 10.00 | |
| Tempest Therapeutics | 0.1 | $1.8M | 1.0M | 1.74 | |
| Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.0 | $1.5M | 150k | 9.91 | |
| Kronos Bio | 0.0 | $1.1M | 327k | 3.35 | |
| Turmeric Acquisition Corp Cl A | 0.0 | $1.0M | 100k | 10.00 | |
| Reata Pharmaceuticals Cl A | 0.0 | $967k | 39k | 25.14 | |
| Nuvalent Inc-a (NUVL) | 0.0 | $796k | 41k | 19.43 | |
| Iteos Therapeutics | 0.0 | $771k | 41k | 19.05 | |
| Caremax *w Exp 06/08/202 | 0.0 | $709k | 100k | 7.09 | |
| Eucrates Biomedical Acqu Cor *w Exp 10/23/202 | 0.0 | $668k | 67k | 10.02 | |
| Frazier Lifesciences Acqu *w Exp 11/30/202 | 0.0 | $665k | 67k | 9.98 | |
| Omega Alpha Spac Cl A | 0.0 | $497k | 50k | 9.94 | |
| Turmeric Acquisition Corp *w Exp 10/08/202 | 0.0 | $333k | 33k | 9.99 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $135k | 67k | 2.03 |